North America accounted for the largest revenue share of global regenerative medicine market, representing a market value of US$ 2,039.8 Million. Due to increasing demand for bone and joint reconstructive surgeries and encouraging government initiatives, North America is estimated to remain the largest market for regenerative medicine (bone and joint) in 2016.
Europe is the second largest market for regenerative medicine, with the region’s high geriatric population fueling adoption at a robust pace.
Request for a FREE sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1326
Key Market Segments Covered:
The global regenerative medicine (bone and joint) market is segmented as follows:
By Technology
- Stem Cell Therapy
- Biomaterial
- Tissue Engineering
By Application
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
Regenerative Medicine (Bone and Joint) Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World
By technology, biomaterials segment accounts for the highest market share globally, owing to favourable reimbursement policies and strong demand for biomaterials. Apart from biomaterials, tissue engineering is the other segment which is quickly gaining traction among end-users, and is projected to witness the highest year-over-year growth among all the technology segments.
On the basis of application, bone graft substitute holds the highest share of the market in terms of value owing to a robust demand of bone graft substitute in orthopaedic treatments. However, complications associated with bone graft substitute can pose challenges to adoption in 2016 and beyond.
Talk to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-1326
While North America and Europe are key to the growth of the regenerative medicine market, rising awareness among healthcare professionals and patients in developing countries of Asia Pacific is expected to open up new opportunities for stakeholders. Favourable government initiatives in growing Asian economies such as China and India has paved the way for regenerative medicine market in the region. Moreover, adoption in developed countries of APAC, such as Japan and South Korea is also fuelling the growth of the market.
Key Market Players:
Key participants in the global regenerative medicine market are: Medtronic, Inc. (INFUSE Bone Graft), DePuy Synthes, Inc. (HEALOS Bone Graft), Orthofix, Inc. (Trinity Evolution), NuVasive, Inc. (Osteocel Plus) and Zimmer Holdings, Inc. (CopiOs Bone Void Filler). The key strategy of these players is to expand globally through distribution agreements, mergers and acquisitions, public-private partnerships and new product development.
Buy this Report Now: https://www.futuremarketinsights.com/checkout/1326
Long-term Outlook:
The global regenerative medicine market (bone and joints) is anticipated to increase at a CAGR of 11.1% during the forecast period from 2015 to 2019. North America will remain the largest market throughout the forecast period, whereas Bone Graft Substitutes will continue to hold the largest share in terms of application.
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs